Brief: Vicore Pharma Holding Proposes No Dividend For FY 2025
27/02/2026 07:12
Feb 27 (Reuters) - Vicore Pharma Holding AB VICOR.ST: BOARD OF DIRECTORS PROPOSES TO ANNUAL GENERAL MEETING THAT NO DIVIDEND BE PAID FOR FINANCIAL YEAR 2025 REVENUE AMOUNTED TO SEK 0.4 MILLION AND SEK 5.1 MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2025 AND 2024, RESPECTIVELY OPERATING LOSS AMOUNTED TO SEK 133.7 MILLION AND SEK 94.1 MILLION FOR THREE MONTHS ENDED DECEMBER 31, 2025 AND 2024, RESPECTIVELY Source text: ID:nMFN3cPm8y Further company coverage: VICOR.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2